世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

カナダの検査、スクリーニング、モニタリング(TSM)機器市場の概観、2028年


Canada Testing, Screening and Monitoring (TSM) Devices Market Overview, 2028

カナダでは、高齢化、慢性疾患の蔓延、医療技術の進歩などの要因により、医療費が徐々に増加している。こうした投資の増加は、医療システムにおける先進的なTSM機器の採用を支えている。糖尿病、心血管疾患、呼吸... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Bonafide Research & Marketing Pvt. Ltd.
ボナファイドリサーチ
2023年11月30日 US$2,250
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
66 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

カナダでは、高齢化、慢性疾患の蔓延、医療技術の進歩などの要因により、医療費が徐々に増加している。こうした投資の増加は、医療システムにおける先進的なTSM機器の採用を支えている。糖尿病、心血管疾患、呼吸器疾患などの慢性疾患の罹患率の上昇により、モニタリングおよびスクリーニング装置の需要が増加している。TSM機器は、これらの慢性疾患の早期発見、管理、モニタリングにおいて重要な役割を果たしている。TSM機器の継続的な技術進歩は、その採用拡大に寄与している。ポイント・オブ・ケア検査、ウェアラブル機器、コネクテッド・ヘルス・ソリューションなどの技術革新は、検査・モニタリング・プロセスの効率と精度を高めている。カナダにおける政府の取り組みや医療政策は、医療インフラや患者の転帰の改善に重点を置くことが多い。医療技術導入に対する支援政策や資金援助は、TSM機器市場の成長を助長する環境を作り出している。予防医療と定期的な健康診断の重要性に対するカナダ国民の意識の高まりが、スクリーニング・モニタリング機器の需要を押し上げている。人々はより積極的に健康管理を行うようになっており、市場の成長に寄与している。カナダは高齢化が進んでおり、高齢者は慢性疾患や継続的なモニタリングが必要な状態に陥りやすい。家庭用を含むTSM機器は、高齢化層の健康管理に欠かせないものとなっている。カナダでは予防医学と病気の早期発見が重視されるようになっている。特に定期的な健康診断やモニタリングを容易にするTSM機器は、こうした医療アプローチに合致しており、市場の成長に寄与している。インフルエンザの流行やCOVID-19のパンデミックなどの感染症の発生は、迅速かつ広範な検査の必要性を浮き彫りにしている。このため、カナダでは検査インフラや技術への投資が増加している。

Bonafide Research社の調査レポート「カナダの検査・スクリーニング・モニタリング(TSM)市場の概要、2028年」によると、カナダの検査・スクリーニング・モニタリング(TSM)市場は、2023年から2028年にかけて年平均成長率8.50%以上で成長すると予測されている。仮想診察や遠隔モニタリングを含む遠隔医療サービスは、カナダで大きな成長を遂げている。この傾向は、患者が自宅で自分の健康を監視できるようにする遠隔医療イニシアチブをサポートするTSMデバイスの需要を促進している。健康モニタリング機能を備えたウェアラブル機器は、カナダで人気を博している。先進的なウェアラブル端末は、心拍数、身体活動、睡眠パターンなど、さまざまな健康指標を追跡することができ、健康モニタリングのより総合的なアプローチに貢献している。カナダの医療システムへのデジタル・ヘルス・ソリューションの統合は進んでいる。TSM機器はコネクテッド・ヘルス・エコシステムの一部であり、機器と医療提供者の間で患者データをシームレスに交換できる。診断プロセスにおける人工知能(AI)と機械学習の応用は増加傾向にある。TSM機器は、診断手順の精度と効率を向上させるために、これらの技術を組み込んでいる。カナダ保健省が定める基準の遵守を含む規制環境は、TSM機器市場の形成において引き続き重要な役割を果たしている。明確な規制経路は、これらの機器の安全性と有効性を保証する。ARおよびVR技術は、医療トレーニング、患者教育、さらには特定の診断手順への応用を見出している。これらの技術をTSM機器に統合することで、全体的な医療体験が向上する。スマートホームヘルスモニタリングのコンセプトは、様々なTSM機器を統合システムに組み込むことである。このシステムにより、個人は家庭環境内で複数の健康パラメーターをシームレスにモニターすることができる。

製品別では、市場は血糖モニター、心拍モニター、マルチパラメーター患者モニタリング装置、薬物アルコールスクリーニング検査、ECG装置、その他に分類される。カナダ国内での薬物乱用や物質使用の増加は、薬物スクリーニング装置の需要を促進する可能性があります。雇用主、法執行機関、医療提供者は、薬物乱用に関連する公衆衛生上の懸念に対処するために、高度な薬物スクリーニング技術に投資する可能性があります。規制要件や職場の安全性に関する懸念に後押しされた職場の薬物検査プログラムの実施は、薬物スクリーニング・セグメントの成長に貢献する可能性がある。運輸、建設、医療などの業界は、厳しい薬物検査方針を定めている場合がある。雇用主は、薬物のない職場環境を確保するために、雇用前および無作為の薬物検査を実施することが増えています。この傾向は、効率的で信頼性の高い薬物スクリーニング装置の需要に貢献する可能性がある。薬物リハビリテーションプログラムおよびイニシアチブの数の増加は、薬物スクリーニング装置に対するより高い需要につながる可能性がある。リハビリテーションを受けている人の定期的なモニタリングは、治療効果に不可欠である。さらに、市場は適応症に基づき、心血管障害・高血圧、糖尿病、妊娠、呼吸器疾患、癌、運動障害、聴覚障害、創傷ケア、その他の適応症(睡眠障害、腎臓障害、神経血管疾患、HIV)に分類される。心臓病や脳卒中などの疾患を含む循環器系疾患はカナダで流行している。人口の高齢化とライフスタイル要因が心血管疾患の高い発生率に寄与しており、検査、スクリーニング、モニタリング機器の需要を促進している。高血圧は一般的な心血管危険因子である。カナダでは高血圧の罹患率が上昇しており、継続的なモニタリングと管理の必要性が高まっているため、TSM機器の採用が増加している。急性疾患だけでなく、心血管障害を含む慢性疾患にも対処する全人的な患者ケアモデルは、継続的なモニタリングを伴う可能性がある。統合ケアアプローチはTSM機器の需要に貢献している。

市場はエンドユーザーによって病院、在宅、その他に二分される。在宅モニタリングは、慢性疾患を管理する個人にとって特に重要である。糖尿病、高血圧、心血管疾患などの検査・モニタリング機器により、患者は自宅に居ながらにして治療に積極的に参加することができる。在宅検査・モニタリング機器は、快適で慣れ親しんだ環境で検査や測定を実施できる利便性を提供します。頻繁に診療所を受診する必要がなく、定期的なモニタリングが可能であれば、患者は定期的なモニタリング・ルーチンを守る可能性が高くなる。家庭用検査機器のデザインは、使いやすさとアクセシビリティを重視している。直感的なインターフェイス、明確な指示、専門的なトレーニングを必要としない機器などが、消費者の間で広く採用される要因となっている。在宅検査・モニタリングソリューションの有用性と利点に対する認知度の向上は、消費者の関心を高める。教育キャンペーンや医療イニシアティブは、日常的な健康管理にこれらの機器の使用を促進する。在宅モニタリングは、個人と医療システムの双方にとってコスト削減に貢献する。不必要な通院や入院を避けることで、医療費全体を削減することができる。デジタルヘルスプラットフォーム、モバイルアプリ、電子カルテとシームレスに統合されたホームモニタリング機器は、全体的なユーザーエクスペリエンスを向上させます。相互接続されたシステムは、患者と医療提供者間のより良いコミュニケーションをサポートします。

本レポートの対象
- 地域カナダ
- 歴史的な年2017
- 基準年2022
- 推定年2023
- 予測年2028

本レポートでカバーする側面
- カナダの検査、スクリーニング、モニタリング市場:その価値と予測、セグメントとともに
- 様々な促進要因と課題
- 進行中のトレンドと開発
- 注目企業
- 戦略的提言

製品別
- 血糖モニター
- 心拍数モニター
- マルチパラメーター患者モニタリング
- 薬物スクリーニング
- 心電計(ECG)
- その他(血圧モニター、パルスオキシメーター、体温モニター、胎児モニター、その他)

エンドユーザー別
- 病院
- ホーム
- その他

適応症別
- 心血管疾患・高血圧
- 糖尿病
- 妊娠
- 呼吸器疾患
- 癌
- 運動障害
- 聴覚障害
- 創傷治療
- その他の適応症

レポートのアプローチ
本レポートは、一次調査と二次調査を組み合わせたアプローチで構成されている。はじめに、市場を把握し、市場に参入している企業をリストアップするために二次調査を行った。二次調査は、プレスリリースや企業の年次報告書などの第三者情報源、政府が作成した報告書やデータベースの分析で構成されている。二次情報源からデータを収集した後、一次調査は、市場がどのように機能しているかについて主要プレーヤーに電話インタビューを行い、市場のディーラーや流通業者と取引コールを行うことによって実施された。その後、消費者を地域別、階層別、年齢層別、性別に均等にセグメンテーションし、消費者への一次調査を開始した。一次データを入手した後は、二次ソースから入手した詳細の検証を開始した。

想定読者
本レポートは、業界コンサルタント、メーカー、サプライヤー、検査・スクリーニング・モニタリング業界に関連する団体・組織、政府機関、その他関係者が市場中心の戦略を調整する際に役立ちます。また、マーケティングやプレゼンテーションだけでなく、業界に関する競合知識を高めることもできます。


ページTOPに戻る


目次

Table of Contents
1. Executive Summary
2. Market Structure
2.1. Market Considerate
2.2. Assumptions
2.3. Limitations
2.4. Abbreviations
2.5. Sources
2.6. Definitions
2.7. Geography
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Canada Macro Economic Indicators
5. Market Dynamics
5.1. Key Findings
5.2. Key Developments - 2021
5.3. Market Drivers & Opportunities
5.4. Market Restraints & Challenges
5.5. Market Trends
5.6. Covid-19 Effect
5.7. Supply chain Analysis
5.8. Policy & Regulatory Framework
5.9. Industry Experts Views
6. Canada Testing, Screening, and Monitoring (TSM) Devices Market Overview
6.1. Market Size By Value
6.2. Market Size and Forecast By Products
6.3. Market Size and Forecast By End User
6.4. Market Size and Forecast By Indication
7. Canada Testing, Screening, and Monitoring (TSM) Devices Market Segmentations
7.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market, By Products
7.1.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Blood Glucose Monitor, 2017-2028
7.1.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Heart Rate Monitors, 2017-2028
7.1.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Multiparameter Patient Monitoring, 2017-2028
7.1.4. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Drug Screening, 2017-2028
7.1.5. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Electrocardiograph (ECG), 2017-2028
7.1.6. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Others, 2017-2028
7.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market, By End User
7.2.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Hospitals, 2017-2028
7.2.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Home, 2017-2028
7.2.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Others, 2017-2028
7.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market, By Indication
7.3.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Cardiovascular Disorders & Hypertension, 2017-2028
7.3.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Diabetes, 2017-2028
7.3.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Pregnancy, 2017-2028
7.3.4. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Respiratory Diseases, 2017-2028
7.3.5. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Cancer, 2017-2028
7.3.6. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Movement Disorders, 2017-2028
7.3.7. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Wound Care, 2017-2028
7.3.8. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Other Indications, 2017-2028
8. Canada Testing, Screening, and Monitoring (TSM) Devices Market Opportunity Assessment
8.1. By Products, 2023 to 2028
8.2. By End User, 2023 to 2028
8.3. By Indication, 2023 to 2028
9. Competitive Landscape
9.1. Porter's Five Forces
9.2. Company Profile
9.2.1. Company 1
9.2.2. Company 2
9.2.3. Company 3
9.2.4. Company 4
9.2.5. Company 5
9.2.6. Company 6
9.2.7. Company 7
9.2.8. Company 8
10. Strategic Recommendations
11. Disclaimer

List of Figures
Figure 1: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 2: Market Attractiveness Index, By Products
Figure 3: Market Attractiveness Index, By End User
Figure 4: Market Attractiveness Index, By Indication
Figure 5: Porter's Five Forces of Canada Testing, Screening, and Monitoring (TSM) Devices Market

List of Table
Table 1: Influencing Factors for Global Testing, Screening, and Monitoring (TSM) Devices Market, 2022
Table 2: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size and Forecast By Products (2017, 2022 & 2028F)
Table 3: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size and Forecast By End User (2017, 2022 & 2028F)
Table 4: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017, 2022 & 2028F)
Table 5: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Blood Glucose Monitor (2017 to 2028) in USD Million
Table 6: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Heart Rate Monitors (2017 to 2028) in USD Million
Table 7: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Multiparameter Patient Monitoring (2017 to 2028) in USD Million
Table 8: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Drug Screening (2017 to 2028) in USD Million
Table 9: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Electrocardiograph (ECG) (2017 to 2028) in USD Million
Table 10: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Others (2017 to 2028) in USD Million
Table 11: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Hospitals (2017 to 2028) in USD Million
Table 12: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Home (2017 to 2028) in USD Million
Table 13: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Others (2017 to 2028) in USD Million
Table 14: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Cardiovascular Disorders & Hypertension (2017 to 2028) in USD Million
Table 15: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Diabetes (2017 to 2028) in USD Million
Table 16: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Pregnancy (2017 to 2028) in USD Million
Table 17: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Respiratory Diseases (2017 to 2028) in USD Million
Table 18: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Cancer (2017 to 2028) in USD Million
Table 19: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Movement Disorders (2017 to 2028) in USD Million
Table 20: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Wound Care (2017 to 2028) in USD Million
Table 21: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Other Indications (2017 to 2028) in USD Million

 

ページTOPに戻る


 

Summary

Canada has been experiencing a gradual increase in healthcare expenditure, driven by factors such as an aging population, the prevalence of chronic diseases, and advancements in medical technologies. This increased investment supports the adoption of advanced TSM devices in the healthcare system. The rising incidence of chronic diseases, including diabetes, cardiovascular diseases, and respiratory conditions, has led to an increased demand for monitoring and screening devices. TSM devices play a crucial role in the early detection, management, and monitoring of these chronic conditions. On-going technological advancements in TSM devices contribute to their increased adoption. Innovations such as point-of-care testing, wearable devices, and connected health solutions enhance the efficiency and accuracy of testing and monitoring processes. Government initiatives and healthcare policies in Canada often focus on improving healthcare infrastructure and patient outcomes. Supportive policies and funding for healthcare technology adoption create an environment conducive to the growth of the TSM Devices market. Increasing awareness among the Canadian population about the importance of preventive healthcare and regular health check-ups has driven the demand for screening and monitoring devices. People are becoming more proactive in managing their health, contributing to market growth. Canada has an aging population, and the elderly are more prone to chronic diseases and conditions that require continuous monitoring. TSM devices, including those designed for home use, become crucial in managing the health of an aging demographic. There is a growing emphasis on preventive medicine and early disease detection in Canada. TSM devices, particularly those facilitating regular health screenings and monitoring, align with this healthcare approach, contributing to market growth. Instances of infectious diseases, such as flu outbreaks and the COVID-19 pandemic, highlight the need for rapid and widespread testing. This has led to increased investment in testing infrastructure and technologies in Canada.

According to the research report "Canada Testing, Screening, and Monitoring (TSM) Market Overview, 2028," published by Bonafide Research, the Canada Testing, Screening, and Monitoring (TSM) market is anticipated to grow at more than 8.50% CAGR from 2023 to 2028. Telehealth services, including virtual consultations and remote monitoring, have experienced significant growth in Canada. This trend has propelled the demand for TSM devices that support telehealth initiatives, allowing patients to monitor their health from home. Wearable devices equipped with health monitoring features have gained popularity in Canada. Advanced wearables can track various health metrics, such as heart rate, physical activity, and sleep patterns, contributing to a more holistic approach to health monitoring. The integration of digital health solutions into the Canadian healthcare system is advancing. TSM devices are part of connected health ecosystems, allowing for the seamless exchange of patient data between devices and healthcare providers. The application of artificial intelligence (AI) and machine learning in diagnostic processes is on the rise. TSM devices are incorporating these technologies to improve the accuracy and efficiency of diagnostic procedures. The regulatory environment, including adherence to standards set by Health Canada, continues to play a crucial role in shaping the TSM devices market. A clear regulatory pathway ensures the safety and effectiveness of these devices. AR and VR technologies are finding applications in medical training, patient education, and even certain diagnostic procedures. The integration of these technologies into TSM devices enhances the overall healthcare experience. The concept of smart home health monitoring involves the integration of various TSM devices into a unified system. This system allows individuals to monitor multiple health parameters seamlessly within their home environment.

In terms of product the market is categorized into Blood Glucose Monitor, Heart Rate Monitors, Multi Parameter Patient Monitoring Device, Drug Alcohol Screening Testing, ECG Devices and others. A rise in drug abuse and substance use within Canada can drive the demand for drug screening devices. Employers, law enforcement agencies, and healthcare providers may invest in advanced drug screening technologies to address public health concerns related to drug abuse. The implementation of workplace drug testing programs, driven by regulatory requirements and concerns about workplace safety, can contribute to the growth of the Drug Screening segment. Industries such as transportation, construction, and healthcare may have stringent drug testing policies. Employers may increasingly implement pre-employment and random drug testing to ensure a drug-free workplace environment. This trend can contribute to the demand for efficient and reliable drug screening devices. An increase in the number of drug rehabilitation programs and initiatives may lead to a higher demand for drug screening devices. Regular monitoring of individuals undergoing rehabilitation can be essential for treatment efficacy. Furthermore the market is categorized into Cardiovascular Disorders & Hypertension, Diabetes, Pregnancy, Respiratory Diseases, Cancer, Movement Disorders, Hearing Disorders, Wound Care and Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV) based on indication. Cardiovascular disorders, including conditions such as heart disease and stroke, are prevalent in Canada. The aging population and lifestyle factors contribute to the high incidence of cardiovascular diseases, driving the demand for testing, screening, and monitoring devices. Hypertension (high blood pressure) is a common cardiovascular risk factor. The rising incidence of hypertension in Canada contributes to the need for continuous monitoring and management, leading to increased adoption of TSM devices. Holistic patient care models that address not only acute conditions but also chronic diseases, including cardiovascular disorders, may involve continuous monitoring. Integrated care approaches contribute to the demand for TSM devices.

The market is bifurcated into Hospitals, Home and others based on end user. Home monitoring is particularly crucial for individuals managing chronic conditions. Testing and monitoring devices for conditions like diabetes, hypertension, and cardiovascular diseases allow patients to actively participate in their care from the comfort of their homes. Home testing and monitoring devices offer the convenience of conducting tests and measurements in a comfortable and familiar environment. Patients are more likely to adhere to regular monitoring routines when it can be done without the need for frequent clinic visits. The design of home testing devices emphasizes user-friendliness and accessibility. Intuitive interfaces, clear instructions, and devices that do not require specialized training contribute to their widespread adoption among consumers. Increased awareness of the availability and benefits of home-based testing and monitoring solutions drives consumer interest. Educational campaigns and healthcare initiatives promote the use of these devices for routine health management. Home monitoring can contribute to cost savings for both individuals and healthcare systems. Avoiding unnecessary clinic visits and hospital stays can reduce overall healthcare expenditures. Home monitoring devices that seamlessly integrate with digital health platforms, mobile apps, and electronic health records enhance the overall user experience. Interconnected systems support better communication between patients and healthcare providers.

Considered in this report:
• Geography: Canada
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Canada Testing, Screening and Monitoring market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product:
• Blood Glucose Monitor
• Heart Rate Monitors
• Multiparameter Patient Monitoring
• Drug Screening
• Electrocardiograph (ECG)
• Others (Blood Pressure Monitoring Devices, Pulse Oximeter, Patient Temperature Monitoring, Fetal Monitoring Devices, Others)

By End User:
• Hospitals
• Home
• Others

By Indication:
• Cardiovascular Disorders & Hypertension
• Diabetes
• Pregnancy
• Respiratory Diseases
• Cancer
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Testing, Screening and Monitoring industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.



ページTOPに戻る


Table of Contents

Table of Contents
1. Executive Summary
2. Market Structure
2.1. Market Considerate
2.2. Assumptions
2.3. Limitations
2.4. Abbreviations
2.5. Sources
2.6. Definitions
2.7. Geography
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Canada Macro Economic Indicators
5. Market Dynamics
5.1. Key Findings
5.2. Key Developments - 2021
5.3. Market Drivers & Opportunities
5.4. Market Restraints & Challenges
5.5. Market Trends
5.6. Covid-19 Effect
5.7. Supply chain Analysis
5.8. Policy & Regulatory Framework
5.9. Industry Experts Views
6. Canada Testing, Screening, and Monitoring (TSM) Devices Market Overview
6.1. Market Size By Value
6.2. Market Size and Forecast By Products
6.3. Market Size and Forecast By End User
6.4. Market Size and Forecast By Indication
7. Canada Testing, Screening, and Monitoring (TSM) Devices Market Segmentations
7.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market, By Products
7.1.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Blood Glucose Monitor, 2017-2028
7.1.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Heart Rate Monitors, 2017-2028
7.1.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Multiparameter Patient Monitoring, 2017-2028
7.1.4. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Drug Screening, 2017-2028
7.1.5. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Electrocardiograph (ECG), 2017-2028
7.1.6. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Others, 2017-2028
7.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market, By End User
7.2.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Hospitals, 2017-2028
7.2.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Home, 2017-2028
7.2.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Others, 2017-2028
7.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market, By Indication
7.3.1. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Cardiovascular Disorders & Hypertension, 2017-2028
7.3.2. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Diabetes, 2017-2028
7.3.3. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Pregnancy, 2017-2028
7.3.4. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Respiratory Diseases, 2017-2028
7.3.5. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Cancer, 2017-2028
7.3.6. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Movement Disorders, 2017-2028
7.3.7. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Wound Care, 2017-2028
7.3.8. Canada Testing, Screening, and Monitoring (TSM) Devices Market Size, By Other Indications, 2017-2028
8. Canada Testing, Screening, and Monitoring (TSM) Devices Market Opportunity Assessment
8.1. By Products, 2023 to 2028
8.2. By End User, 2023 to 2028
8.3. By Indication, 2023 to 2028
9. Competitive Landscape
9.1. Porter's Five Forces
9.2. Company Profile
9.2.1. Company 1
9.2.2. Company 2
9.2.3. Company 3
9.2.4. Company 4
9.2.5. Company 5
9.2.6. Company 6
9.2.7. Company 7
9.2.8. Company 8
10. Strategic Recommendations
11. Disclaimer

List of Figures
Figure 1: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size By Value (2017, 2022 & 2028F) (in USD Million)
Figure 2: Market Attractiveness Index, By Products
Figure 3: Market Attractiveness Index, By End User
Figure 4: Market Attractiveness Index, By Indication
Figure 5: Porter's Five Forces of Canada Testing, Screening, and Monitoring (TSM) Devices Market

List of Table
Table 1: Influencing Factors for Global Testing, Screening, and Monitoring (TSM) Devices Market, 2022
Table 2: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size and Forecast By Products (2017, 2022 & 2028F)
Table 3: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size and Forecast By End User (2017, 2022 & 2028F)
Table 4: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size and Forecast By Indication (2017, 2022 & 2028F)
Table 5: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Blood Glucose Monitor (2017 to 2028) in USD Million
Table 6: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Heart Rate Monitors (2017 to 2028) in USD Million
Table 7: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Multiparameter Patient Monitoring (2017 to 2028) in USD Million
Table 8: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Drug Screening (2017 to 2028) in USD Million
Table 9: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Electrocardiograph (ECG) (2017 to 2028) in USD Million
Table 10: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Others (2017 to 2028) in USD Million
Table 11: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Hospitals (2017 to 2028) in USD Million
Table 12: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Home (2017 to 2028) in USD Million
Table 13: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Others (2017 to 2028) in USD Million
Table 14: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Cardiovascular Disorders & Hypertension (2017 to 2028) in USD Million
Table 15: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Diabetes (2017 to 2028) in USD Million
Table 16: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Pregnancy (2017 to 2028) in USD Million
Table 17: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Respiratory Diseases (2017 to 2028) in USD Million
Table 18: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Cancer (2017 to 2028) in USD Million
Table 19: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Movement Disorders (2017 to 2028) in USD Million
Table 20: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Wound Care (2017 to 2028) in USD Million
Table 21: Canada Testing, Screening, and Monitoring (TSM) Devices Market Size of Other Indications (2017 to 2028) in USD Million

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(環境・エネルギー)の最新刊レポート


よくあるご質問


Bonafide Research & Marketing Pvt. Ltd.社はどのような調査会社ですか?


Bonafide Research & Marketing Pvt. Ltd.は、最新の経済、人口統計、貿易、市場データを提供する市場調査・コンサルティング会社です。調査レポート、カスタムレポート、コ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る